Stay updated on Her2-BATS and Pembrolizumab in Metastatic Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Her2-BATS and Pembrolizumab in Metastatic Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Her2-BATS and Pembrolizumab in Metastatic Breast Cancer Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.6, replacing the previous Revision: v3.6.5. This update appears to reflect a small backend or site-wide revision tag rather than a change to study content or user-facing features.
    Difference
    0.1%
    Check dated 2026-08-31T18:28:24.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    Page revision updated from v3.6.4 to v3.6.5, signaling a new build of the page. No user-facing content changes to the study details are indicated.
    Difference
    0.1%
    Check dated 2026-08-10T13:55:09.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.3 to v3.6.4, indicating a newer build of the page. This update appears to affect only metadata or internal tooling and does not alter the study content or user-facing information.
    Difference
    0.1%
    Check dated 2026-07-27T06:20:53.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    Footer revision updated from v3.6.2 to v3.6.3, indicating a new site version.
    Difference
    0.1%
    Check dated 2026-07-05T13:17:33.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    The page's revision history shows a new version (v3.6.2), indicating a small metadata update to the study record.
    Difference
    0.1%
    Check dated 2026-06-28T06:27:09.000Z thumbnail image
  8. Check
    82 days ago
    Change Detected
    Summary
    New guidance sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and a recruitment status note indicates recruitment is closed. A heading was reformatted from 'Intervention / Treatment' to 'Intervention/Treatment' to align with other sections.
    Difference
    0.4%
    Check dated 2026-06-14T06:50:32.000Z thumbnail image

Stay in the know with updates to Her2-BATS and Pembrolizumab in Metastatic Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Her2-BATS and Pembrolizumab in Metastatic Breast Cancer Clinical Trial page.